![]() |
市場調查報告書
商品編碼
1856945
全球血液銀行和儲存設備市場:預測至2032年-按產品、技術、應用、最終用戶和地區分類的分析Blood Banking & Storage Equipment Market Forecasts to 2032 - Global Analysis By Product (Blood Storage Refrigerators, Blood Transport Systems, Blood Plasma Freezers and Other Products), Technology, Application, End User and By Geography |
||||||
據 Stratistics MRC 稱,全球血庫和儲存設備市場預計到 2025 年將達到 170 億美元,到 2032 年將達到 234 億美元,預測期內複合年成長率為 4.6%。
血庫和血液儲存設備是指用於採集、處理、保存和儲存血液及其成分的專用醫療設備和系統。這包括血液冰箱、血漿冷凍庫、血小板培養箱、離心機、血庫分析儀等。這些設備旨在維持最佳溫度和無菌狀態,確保用於輸血和醫療程序的血液製品的安全性、有效性和可追溯性。它們在醫院、診斷實驗室和血庫中發揮著至關重要的作用,有助於高效的庫存管理、合規性和緊急準備。先進的技術還實現了自動化、即時監控和更精準的供受者匹配,從而帶來更好的醫療效果。
輸血需求增加
輸血需求的不斷成長是血液銀行和儲存設備市場的主要驅動力。創傷、手術、癌症和貧血等慢性疾病病例的增加以及人口老化,都促使人們對安全高效的血液儲存方式提出了更高的要求。醫院和醫療機構正在擴大血液管理能力,這進一步推動了對先進儲存設備的需求。此外,人們對自願捐血的認知不斷提高,以及醫療系統對緊急準備的日益重視,也進一步促進了這一趨勢。
先進設備高成本
先進的血庫和血庫設備成本高昂,是限制市場成長的主要因素。諸如血漿冷凍機、自動化分析儀和溫控儲存設備等先進設備需要大量的資金投入。這些成本對於規模較小的醫療機構和血庫而言可能難以承受,尤其是在發展中地區。此外,持續的維護、校準以及遵守監管標準也會增加營運成本。這些經濟負擔會限制資源匱乏地區對先進設備的採用,並延緩現代化進程。
技術進步
技術進步為市場帶來了巨大的機會。自動化血液處理系統、RFID庫存追蹤和智慧溫度監控等創新技術提高了效率、安全性和可追溯性。這些技術減少了人為錯誤,改善了儲存條件,並有助於符合監管要求。與數位健康平台和即時數據分析的整合也有助於更好地進行決策和供受者配對。隨著醫療保健系統的現代化,對智慧、互聯和節能儲存解決方案的需求預計將推動市場顯著成長。
嚴格的監管要求
嚴格的監管要求對市場構成重大威脅。遵守血液安全、儲存和可追溯性的國際標準需要嚴格的測試、記錄和認證。這些法規可能會延遲產品核准,並增加製造商的研發成本。此外,安全通訊協定和品管措施的頻繁更新也要求持續調整。對於醫療服務提供者而言,滿足這些標準需要培訓、審核和基礎設施升級,這可能會耗費資源並阻礙新技術的應用。
新冠疫情對血庫和血液儲存設備市場產生了多方面的影響。雖然擇期手術減少,但對康復者血漿和緊急血液供應的需求卻激增。這場危機凸顯了健全的血液儲存基礎設施的重要性,並加速了自動化和非接觸式技術的應用。供應鏈中斷和捐血者短缺帶來了挑戰,但也推動了行動採血車和遠端監控系統的創新。預計疫情後市場將受益於對醫療保健韌性和緊急準備的重新投資。
預計在預測期內,診斷中心板塊將成為最大的細分市場。
由於診斷中心數量不斷增加,且在血液檢測、交叉配血和疾病篩檢方面發揮至關重要的作用,預計在預測期內,診斷中心細分市場將佔據最大的市場佔有率。這些中心需要可靠的儲存解決方案來維持血液樣本和成分的完整性。隨著對精準診斷和預防性醫療保健需求的不斷成長,診斷中心正在投資先進設備,以確保合規性、縮短週轉時間並支援日益成長的血液相關檢測服務量。
預計在預測期內,血漿冷凍機細分市場將實現最高的複合年成長率。
由於血漿在免疫力缺乏、出血性疾病和新冠肺炎相關治療等領域的應用日益廣泛,預計血漿冷凍設備領域在預測期內將達到最高成長率。血漿需要超低溫儲存才能保持其療效,這推動了對專用冷凍庫的需求。能源效率、溫度控制和警報系統等技術進步進一步提升了產品的吸引力。隨著血漿療法在全球範圍內的推廣,對可靠且擴充性的儲存解決方案的需求也在持續成長。
預計亞太地區將在預測期內佔據最大的市場佔有率。人口快速成長、醫療保健投資不斷增加以及捐血意識的提高是該地區的主要促進因素。中國、印度和日本等國家正在擴大醫療保健基礎設施並引進先進的醫療技術。政府為提高血液安全性和供應量而採取的舉措,以及慢性病負擔的日益加重,進一步推動了全部區域對現代化血液儲存和處理設備的需求。
預計北美在預測期內將實現最高的複合年成長率。這主要歸功於該地區先進的醫療基礎設施、健全的法規結構以及對最尖端科技的廣泛應用。血液成分需求的成長、慢性病盛行率的上升以及完善的血庫和診斷中心網路也推動了這一趨勢。此外,輸血醫學領域的持續研究以及數位醫療解決方案的整合,使北美在血庫創新和擴張方面處於領先地位。
According to Stratistics MRC, the Global Blood Banking & Storage Equipment Market is accounted for $17.0 billion in 2025 and is expected to reach $23.4 billion by 2032 growing at a CAGR of 4.6% during the forecast period. Blood banking and storage equipment refers to specialized medical devices and systems used for the collection, processing, preservation, and storage of blood and its components. These include blood refrigerators, plasma freezers, platelet incubators, centrifuges, and blood bank analyzers. Designed to maintain optimal temperature and sterility, this equipment ensures the safety, viability, and traceability of blood products for transfusions and medical procedures. It plays a critical role in hospitals, diagnostic labs, and blood banks by supporting efficient inventory management, regulatory compliance, and emergency preparedness. Advanced technologies also enable automation, real-time monitoring, and improved donor-to-recipient matching for better healthcare outcomes.
Increasing demand for blood transfusions
The growing demand for blood transfusions is a key driver of the Blood Banking & Storage Equipment Market. Rising incidences of trauma, surgeries, chronic diseases like cancer and anemia, and aging populations are increasing the need for safe and efficient blood storage. Hospitals and healthcare facilities are expanding their blood management capabilities, which boost the demand for advanced storage equipment. This trend is further supported by growing awareness of voluntary blood donation and the need for emergency preparedness in healthcare systems.
High cost of advanced equipment
The high cost of advanced blood banking and storage equipment poses a significant restraint to market growth. Sophisticated devices such as plasma freezers, automated analyzers, and temperature-controlled storage units require substantial capital investment. These costs can be prohibitive for smaller healthcare facilities and blood banks, particularly in developing regions. Additionally, ongoing maintenance, calibration, and compliance with regulatory standards add to operational expenses. This financial burden may limit adoption and slow modernization efforts in resource-constrained environments.
Technological advancements
Technological advancements present a major opportunity for the market. Innovations such as automated blood processing systems, RFID-enabled inventory tracking, and smart temperature monitoring enhance efficiency, safety, and traceability. These technologies reduce human error, improve storage conditions, and support regulatory compliance. Integration with digital health platforms and real-time data analytics also enables better decision-making and donor-recipient matching. As healthcare systems modernize, the demand for intelligent, connected, and energy-efficient storage solutions is expected to drive significant market growth.
Stringent regulatory requirements
Stringent regulatory requirements represent a key threat to the market. Compliance with international standards for blood safety, storage, and traceability demands rigorous testing, documentation, and certification. These regulations can delay product approvals and increase development costs for manufacturers. Additionally, frequent updates to safety protocols and quality control measures require continuous adaptation. For healthcare providers, meeting these standards involves training, audits, and infrastructure upgrades, which can strain resources and hinder the adoption of new technologies.
The COVID-19 pandemic had a mixed impact on the Blood Banking & Storage Equipment Market. While elective procedures declined, the need for convalescent plasma and emergency blood supplies surged. The crisis highlighted the importance of robust blood storage infrastructure and accelerated the adoption of automated and contactless technologies. Supply chain disruptions and donor shortages posed challenges, but also spurred innovation in mobile collection units and remote monitoring systems. Post-pandemic, the market is expected to benefit from renewed investments in healthcare resilience and preparedness.
The diagnostic centers segment is expected to be the largest during the forecast period
The diagnostic centers segment is expected to account for the largest market share during the forecast period, due to increasing number of diagnostic laboratories and their critical role in blood testing, cross-matching, and disease screening. These centers require reliable storage solutions to maintain the integrity of blood samples and components. With rising demand for accurate diagnostics and preventive healthcare, diagnostic centers are investing in advanced equipment to ensure compliance, improve turnaround times, and support growing volumes of blood-related testing services.
The blood plasma freezers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the blood plasma freezers segment is predicted to witness the highest growth rate, due to increasing use of plasma in therapeutic applications, including treatment for immune deficiencies, bleeding disorders, and COVID-19-related therapies. Plasma requires ultra-low temperature storage to preserve its efficacy, driving demand for specialized freezers. Technological improvements in energy efficiency, temperature control, and alarm systems are further enhancing product appeal. As plasma-based treatments expand globally, the need for reliable and scalable storage solutions continues to rise.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, as rapid population growth, increasing healthcare investments, and rising awareness of blood donation are key drivers in the region. Countries like China, India, and Japan are expanding their healthcare infrastructure and adopting advanced medical technologies. Government initiatives to improve blood safety and availability, along with the growing burden of chronic diseases, are further boosting demand for modern blood storage and processing equipment across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region's advanced healthcare infrastructure, strong regulatory framework, and high adoption of cutting-edge technologies. Increasing demand for blood components, rising prevalence of chronic illnesses, and a well-established network of blood banks and diagnostic centers contribute to this trend. Additionally, ongoing research in transfusion medicine and the integration of digital health solutions position North America as a leader in blood storage innovation and expansion.
Key players in the market
Some of the key players in Blood Banking & Storage Equipment Market include Thermo Fisher Scientific, Angelantoni Life Science, Haier Biomedical, Labcold Ltd, Terumo Corporation, Panasonic Healthcare, Fresenius Kabi, Sarstedt AG & Co. KG, Bio-Rad Laboratories, Boekel Scientific, Becton, Dickinson and Company (BD), Lmb Technologie GmbH, Azenta Life Sciences, Macopharma, and Helmer Scientific.
In July 2025, Thermo Fisher will acquire Sanofi's sterile manufacturing facility in Ridgefield, New Jersey and continue producing Sanofi's therapies there. They also plan to expand the site's capacity to serve broader pharmaceutical and biotech demand. More than 200 existing staff will join Thermo Fisher as the transaction closes in the second half of 2025.
In January 2025, Pioneer Group and Thermo Fisher Scientific unite to bolster UK and Irish biotech startups. This collaboration offers entrepreneurs access to training, technical support, bespoke equipment, and consumables. Graduates of Pioneer's equity-free Accelerator Programme gain exclusive access to Thermo Fisher's reward system, aiding in laboratory setup.